Oncovita Company
Oncovita is a biotech company focused on developing innovative medications and vaccines, particularly anti-cancer therapies, to save lives. Oncovita is building a candidate pipeline around disruptive technology and its proprietary platform MeasovirTM. Changes in the measles viral genome are chosen by technology engineers to greatly boost its anti-tumor effects.
Funding Status:
private
Last Funding Date:
2023-11-22
Headquarters:
Paris,Ile-de-France,France,Europe
Total Funding:
8710318
Founded Date:
2015-01-01
Industry:
Quantum Biology
Super Industry:
Quantum Science Applications
Funding Stage:
Seed
Funding Total Value:
8000000
Last Funding Total Usd:
4899554
Last Funding Total Currency:
EUR
Last Funding Total Value:
4500000